Overview
Magdalini Migkou practices in Athens, Greece. Migkou is rated as a Distinguished expert by MediFind in the treatment of Multiple Myeloma. Their top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Smoldering Multiple Myeloma.
Their clinical research consists of co-authoring 108 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 64 articles in the study of Multiple Myeloma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaMigkou isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Primary AmyloidosisMigkou isAdvanced. Learn about Primary Amyloidosis.
- Smoldering Multiple Myeloma
- Waldenstrom Macroglobulinemia
- Experienced
- AgranulocytosisMigkou isExperienced. Learn about Agranulocytosis.
- Atypical PneumoniaMigkou isExperienced. Learn about Atypical Pneumonia.
- COVID-19Migkou isExperienced. Learn about COVID-19.
- Gaucher DiseaseMigkou isExperienced. Learn about Gaucher Disease.
- HypercalcemiaMigkou isExperienced. Learn about Hypercalcemia.
- Light Chain Deposition Disease (LCDD)